170 related articles for article (PubMed ID: 23642315)
21. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.
Platt L; Minozzi S; Reed J; Vickerman P; Hagan H; French C; Jordan A; Degenhardt L; Hope V; Hutchinson S; Maher L; Palmateer N; Taylor A; Bruneau J; Hickman M
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD012021. PubMed ID: 28922449
[TBL] [Abstract][Full Text] [Related]
22. The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review.
Gillies M; Palmateer N; Hutchinson S; Ahmed S; Taylor A; Goldberg D
BMC Public Health; 2010 Nov; 10():721. PubMed ID: 21092300
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
[TBL] [Abstract][Full Text] [Related]
24. Supervised Injection Facility Utilization Patterns: A Prospective Cohort Study in Vancouver, Canada.
Kennedy MC; Klassen DC; Dong H; Milloy MS; Hayashi K; Kerr TH
Am J Prev Med; 2019 Sep; 57(3):330-337. PubMed ID: 31377091
[TBL] [Abstract][Full Text] [Related]
25. An external evaluation of a peer-run "unsanctioned" syringe exchange program.
Wood E; Kerr T; Spittal PM; Small W; Tyndall MW; O'Shaughnessy MV; Schechter MT
J Urban Health; 2003 Sep; 80(3):455-64. PubMed ID: 12930883
[TBL] [Abstract][Full Text] [Related]
26. Qualitative evaluation of a peer-based needle syringe programme in Vietnam.
Ngo AD; Schmich L; Higgs P; Fischer A
Int J Drug Policy; 2009 Mar; 20(2):179-82. PubMed ID: 18242971
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p study.
Cunningham EB; Hajarizadeh B; Amin J; Bretana N; Dore GJ; Degenhardt L; Larney S; Luciani F; Lloyd AR; Grebely J;
Int J Drug Policy; 2018 Apr; 54():18-25. PubMed ID: 29367011
[TBL] [Abstract][Full Text] [Related]
28. Performance and image enhancing drug injectors' access to needle syringe programs: Responding to a public policy dilemma.
van Beek I; Chronister KJ
Int J Drug Policy; 2015 Sep; 26(9):868-74. PubMed ID: 26118797
[TBL] [Abstract][Full Text] [Related]
29. Needle exchange is not enough: lessons from the Vancouver injecting drug use study.
Strathdee SA; Patrick DM; Currie SL; Cornelisse PG; Rekart ML; Montaner JS; Schechter MT; O'Shaughnessy MV
AIDS; 1997 Jul; 11(8):F59-65. PubMed ID: 9223727
[TBL] [Abstract][Full Text] [Related]
30. Cessation of injecting drug use among street-based youth.
Steensma C; Boivin JF; Blais L; Roy E
J Urban Health; 2005 Dec; 82(4):622-37. PubMed ID: 16195471
[TBL] [Abstract][Full Text] [Related]
31. Needle and syringe sharing practices among injecting drug users in Tehran: a comparison of two neighborhoods, one with and one without a needle and syringe program.
Zamani S; Vazirian M; Nassirimanesh B; Razzaghi EM; Ono-Kihara M; Mortazavi Ravari S; Gouya MM; Kihara M
AIDS Behav; 2010 Aug; 14(4):885-90. PubMed ID: 18483849
[TBL] [Abstract][Full Text] [Related]
32. Factors associated with HIV testing among male injecting drug users: findings from a cross-sectional behavioural and biological survey in Manipur and Nagaland, India.
Ganju D; Ramesh S; Saggurti N
Harm Reduct J; 2016 Jun; 13(1):21. PubMed ID: 27324253
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal Factors Associated with Used Syringe Lending Among HIV-Positive Antiretroviral Therapy-Naïve People Who Inject Drugs in a Canadian Setting.
Blumenkrans E; Socías ME; Richardson L; Kerr T; Shoveller J; Montaner J; Milloy MJ
AIDS Behav; 2020 Jul; 24(7):2163-2168. PubMed ID: 32026249
[TBL] [Abstract][Full Text] [Related]
34. The effect of syringe exchange use on high-risk injection drug users: a cohort study.
Bluthenthal RN; Kral AH; Gee L; Erringer EA; Edlin BR
AIDS; 2000 Mar; 14(5):605-11. PubMed ID: 10780722
[TBL] [Abstract][Full Text] [Related]
35. Operating needle exchange programmes in the hills of Thailand.
Gray J
AIDS Care; 1995; 7(4):489-99. PubMed ID: 8547363
[TBL] [Abstract][Full Text] [Related]
36. A comparison of syringe disposal practices among injection drug users in a city with versus a city without needle and syringe programs.
Tookes HE; Kral AH; Wenger LD; Cardenas GA; Martinez AN; Sherman RL; Pereyra M; Forrest DW; LaLota M; Metsch LR
Drug Alcohol Depend; 2012 Jun; 123(1-3):255-9. PubMed ID: 22209091
[TBL] [Abstract][Full Text] [Related]
37. Needle and syringe exchange programmes and prevalence of HIV infection among intravenous drug users in China.
Luo W; Wu Z; Poundstone K; McGoogan JM; Dong W; Pang L; Rou K; Wang C; Cao X
Addiction; 2015 Jan; 110 Suppl 1():61-7. PubMed ID: 25533865
[TBL] [Abstract][Full Text] [Related]
38. Injecting drug use in prison: prevalence and implications for needle exchange policy.
Wright NM; Tompkins CN; Farragher TM
Int J Prison Health; 2015; 11(1):17-29. PubMed ID: 25751704
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study.
Lloyd-Smith E; Wood E; Zhang R; Tyndall MW; Montaner JS; Kerr T
BMC Public Health; 2008 Dec; 8():405. PubMed ID: 19068133
[TBL] [Abstract][Full Text] [Related]
40. The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users.
Wood E; Kerr T; Spittal PM; Li K; Small W; Tyndall MW; Hogg RS; O'Shaughnessy MV; Schechter MT
J Acquir Immune Defic Syndr; 2003 Jan; 32(1):2-8. PubMed ID: 12514408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
